GUANGZHOU PINSHANGZHEN TRADING CO., LTD. – Trademark Portfolio

Entity Type: 99

GUANGZHOU PINSHANGZHEN TRADING CO., LTD. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include FIBEE and YIYAME. The owner is based in GUANGZHOU.

C238, 2F, NO. 1 SHAYUAN MIDDLE ROAD, LICHENG ST, ZENGCHENG DIST,

GUANGZHOU 510000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

YIYAME
YIYAME
Registered 2023
FIBEE
FIBEE
Registered 2017

Trademark Classifications

GUANGZHOU PINSHANGZHEN TRADING CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does GUANGZHOU PINSHANGZHEN TRADING CO., LTD. have?

GUANGZHOU PINSHANGZHEN TRADING CO., LTD. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does GUANGZHOU PINSHANGZHEN TRADING CO., LTD. file in?

GUANGZHOU PINSHANGZHEN TRADING CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are GUANGZHOU PINSHANGZHEN TRADING CO., LTD.'s most well-known trademarks?

GUANGZHOU PINSHANGZHEN TRADING CO., LTD.'s registered trademark portfolio includes well-known marks such as FIBEE and YIYAME. These are among 2 currently registered trademarks in the portfolio.

What is GUANGZHOU PINSHANGZHEN TRADING CO., LTD.'s trademark registration success rate?

GUANGZHOU PINSHANGZHEN TRADING CO., LTD. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.